Literature DB >> 14618368

Distribution of intramyocardially injected extracellular MR contrast medium: effects of concentration and volume.

Gabriele A Krombach1, Ronald Baireuther, Charles B Higgins, Maythem Saeed.   

Abstract

The purpose of this study was to assess the potential of intramyocardially injected Gd-DTPA solution as a marker for distribution of intramyocardially delivered therapeutic solutions. The effects of concentration and volume of the extracellular MR contrast medium Gd-DTPA on signal intensity and spatial extent of enhancement was determined after intramyocardial delivery. In anesthetized pigs (n=11), mixtures of Gd-DTPA (0.15, 0.1 and 0.05 mmol/ml) and Evan's blue tissue dye (3%) were injected into the wall of the left ventricle. In each pig 1 ml of 0.15 mmol/ml, 2 ml of 0.1 ml and 3 ml of 0.05 mmol/ml Gd-DTPA were injected remote from each other. Arterial blood pressure, heart rate and ECG were monitored throughout the procedure. Five minutes after injections were performed, the pigs were killed and the hearts excised. T1-weighted spin-echo MR images were acquired to measure regional signal intensity (SI) and extent of the enhanced regions. The hearts were sliced and mass of blue stained regions was determined and compared with mass of enhanced areas on MRI. Gd-DTPA significantly (p<0.001) increased regional SI compared with remote myocardium in a concentration dependent fashion (109 +/- 4% at 0.05 mmol/ml, 202 +/- 7% at 0.1, and 327 +/- 6% at 0.15) while the mass of enhanced region was 0.6 +/- 0.1 g after injection of 1 ml, 1.4 +/- 0.2 g after 2 ml and 2.3 +/- 0.3 g after 3 ml (p<0.001). Regression and Bland-Altman analysis revealed that there was close correlation and agreement between MRI and histomorphometry (r=0.98, p<0.001). Magnitude and spatial extent of enhancement depend on concentration and volume of injected contrast medium. Intramyocardial injection of extracellular MR contrast media may be useful as a marker for the extent of distribution of intramyocardially delivered therapeutic solutions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14618368     DOI: 10.1007/s00330-003-2148-5

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  26 in total

1.  Magnetic resonance imaging permits in vivo monitoring of catheter-based vascular gene delivery.

Authors:  X Yang; E Atalar; D Li; J M Serfaty; D Wang; A Kumar; L Cheng
Journal:  Circulation       Date:  2001-10-02       Impact factor: 29.690

2.  Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia.

Authors:  D W Losordo; P R Vale; J F Symes; C H Dunnington; D D Esakof; M Maysky; A B Ashare; K Lathi; J M Isner
Journal:  Circulation       Date:  1998 Dec 22-29       Impact factor: 29.690

3.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

4.  Sequential magnetic resonance monitoring of pulmonary flow with endovascular stents placed across the pulmonary valve in growing Swine.

Authors:  T Kuehne; M Saeed; G Reddy; H Akbari; K Gleason; D Turner; D Teitel; P Moore; C B Higgins
Journal:  Circulation       Date:  2001-11-06       Impact factor: 29.690

5.  Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease.

Authors:  T K Rosengart; L Y Lee; S R Patel; T A Sanborn; M Parikh; G W Bergman; R Hachamovitch; M Szulc; P D Kligfield; P M Okin; R T Hahn; R B Devereux; M R Post; N R Hackett; T Foster; T M Grasso; M L Lesser; O W Isom; R G Crystal
Journal:  Circulation       Date:  1999-08-03       Impact factor: 29.690

6.  Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease.

Authors:  B Schumacher; P Pecher; B U von Specht; T Stegmann
Journal:  Circulation       Date:  1998-02-24       Impact factor: 29.690

7.  Magnetic resonance characterization of the peri-infarction zone of reperfused myocardial infarction with necrosis-specific and extracellular nonspecific contrast media.

Authors:  M Saeed; G Lund; M F Wendland; J Bremerich; H Weinmann; C B Higgins
Journal:  Circulation       Date:  2001-02-13       Impact factor: 29.690

8.  Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart.

Authors:  D F Lazarous; M Scheinowitz; M Shou; E Hodge; S Rajanayagam; S Hunsberger; W G Robison; J A Stiber; R Correa; S E Epstein
Journal:  Circulation       Date:  1995-01-01       Impact factor: 29.690

9.  Depiction of reperfused myocardial infarction using contrast-enhanced spin echo and gradient echo magnetic resonance imaging.

Authors:  J F Geschwind; M Saeed; M F Wendland; C B Higgins
Journal:  Invest Radiol       Date:  1998-07       Impact factor: 6.016

10.  Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart.

Authors:  C A Mack; S R Patel; E A Schwarz; P Zanzonico; R T Hahn; A Ilercil; R B Devereux; S J Goldsmith; T F Christian; T A Sanborn; I Kovesdi; N Hackett; O W Isom; R G Crystal; T K Rosengart
Journal:  J Thorac Cardiovasc Surg       Date:  1998-01       Impact factor: 6.439

View more
  3 in total

Review 1.  Stem cell therapy: MRI guidance and monitoring.

Authors:  Dara L Kraitchman; Wesley D Gilson; Christine H Lorenz
Journal:  J Magn Reson Imaging       Date:  2008-02       Impact factor: 4.813

Review 2.  MR-guided endovascular interventions: a comprehensive review on techniques and applications.

Authors:  Sebastian Kos; Rolf Huegli; Georg M Bongartz; Augustinus L Jacob; Deniz Bilecen
Journal:  Eur Radiol       Date:  2007-12-11       Impact factor: 5.315

Review 3.  MRI in guiding and assessing intramyocardial therapy.

Authors:  M Saeed; D Saloner; O Weber; A Martin; C Henk; C Higgins
Journal:  Eur Radiol       Date:  2005-01-29       Impact factor: 5.315

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.